Company news

Correvio Pharma Corp news in 2017

Correvio Pharma Corp's news releases, calls and decks from 2017, newest first.

View company

Cardiome Announces Strategic Licensing Agreement To Commercialize Aggrastat In Russia

December 12, 2017

Cardiome Highlights Partner SteadyMed's Agreement With FDA On Pathway To Trevyent NDA Resubmission

December 11, 2017

Cardiome Announces Xydalba(TM) Treatment And Patient Experience Presentations At The 2017 National Opat Conference

December 11, 2017

Cardiome to Present at the 29th Annual Piper Jaffray Healthcare Conference

November 20, 2017

Cardiome Reports Third Quarter 2017 Financial Results

November 14, 2017

Cardiome To Hold Third Quarter 2017 Financial Results Conference Call On November 14

November 7, 2017

Cardiome Announces Expansion of Global Geographic Footprint for Brinavess®

November 2, 2017

Cardiome Announces Commercial Launch of Xydalba(TM) in Three New European Geographies

October 30, 2017

Cardiome Announces Agreement with Basilea for Distribution of Zevtera®/Mabelio® (Ceftobiprole) in Europe and Israel

September 12, 2017

Cardiome to Present at the Rodman & Renshaw 19th Annual Global Investment Conference

September 5, 2017

New Data Presented at European Society of Cardiology Congress 2017 Highlights Clinical Benefit of BRINAVESS®

August 30, 2017

Cardiome Provides U.S. Regulatory Update For BRINAVESS

August 21, 2017

Cardiome Reports Second Quarter 2017 Financial Results

August 8, 2017

Cardiome To Hold Second Quarter 2017 Financial Results Conference Call On August 8

August 1, 2017

Cardiome Announces Health Canada Approval of AGGRASTAT® High Dose Bolus Regimen

July 17, 2017

Cardiome's Partner SteadyMed Submits U.S. New Drug Application for TREVYENT® for the Treatment of Pulmonary Arterial Hypertension

July 3, 2017

Cardiome Announces Licensing Agreement for XYDALBA(TM) (Dalbavancin Hydrochloride) to Support Planned Commercialization in Israel

June 21, 2017

Cardiome Announces Commercial Launch of BRINAVESS® (Vernakalant Hydrochloride) in Canada

June 12, 2017

Cardiome Reports Changes To Senior Management Team

May 16, 2017

Cardiome Reports First Quarter 2017 Financial Results

May 15, 2017

Cardiome Announces Amendment to Term Loan Agreement with CRG-Managed Funds

May 15, 2017

Cardiome To Hold First Quarter 2017 Financial Results Conference Call On May 15

May 8, 2017

Cardiome to Present at the Bloom Burton & Co. 6th Annual Healthcare Investor Conference

April 27, 2017

Cardiome's Partner SteadyMed Announces Successful Completion of Trevyent® Clinical Validation Study

April 6, 2017

Cardiome's Partner SteadyMed Receives Favourable Ruling in its USPTO Inter Partes Review

April 3, 2017

Cardiome Receives Notice of Compliance from Health Canada for its BRINAVESS NDS

March 14, 2017

Cardiome Reports Fourth Quarter and Full Year 2016 Financial Results

March 7, 2017

Cardiome Announces Commercial Launch of Xydalba(TM) (dalbavancin) in France

March 3, 2017

Cardiome To Hold Fourth Quarter And Full Year 2016 Financial Results Conference Call On March 7

February 27, 2017